Breast Cancer Screening in Men.
Yiming GaoSamantha L HellerPublished in: Journal of breast imaging (2024)
Breast cancer screening has been highly successful in women in reducing mortality through early detection. In comparison, clinical detection of breast cancer remains the norm in men, and delay in diagnosis is reflected by a persistent survival disparity compared to women despite advances in modern therapy. Male breast cancer presents an interesting dilemma. While mammography is highly sensitive and specific for male breast cancer, routine screening is not justified by the overall low disease incidence. Yet there has been interest in leveraging mammography in targeted screening of men with identifiable risk factors to allow early detection, and early data may support this approach. The purpose of this article is to explore the potential utility of targeted breast cancer screening in men by examining unique clinical and biologic characteristics of male breast cancers that may lend themselves to mammographic detection. We will also discuss available evidence in screening outcomes in men and summarize recent updates in risk management recommendations in Society guidelines.
Keyphrases
- risk factors
- breast cancer risk
- middle aged
- rheumatoid arthritis
- clinical practice
- type diabetes
- computed tomography
- stem cells
- cardiovascular events
- skeletal muscle
- machine learning
- risk assessment
- magnetic resonance imaging
- cancer therapy
- mass spectrometry
- young adults
- high resolution
- cell therapy
- artificial intelligence
- weight loss
- molecularly imprinted